全部| 求助中| 待确认 按时间排序|按积分排序

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2 study

乔垣结衣 5天前 20 已关闭

[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]

用户Fm8QqQDltcks 5天前 10 已完结

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

用户Cg-WeFzld28Q 5天前 10 已完结

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

乔垣结衣 5天前 50 已完结

Oncolytic virus VG161 in refractory hepatocellular carcinoma

用户7nEFK6amBq5Y 5天前 10 已完结

A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals

用户7nEFK6amBq5Y 5天前 10 已完结

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

乔垣结衣 5天前 50 已关闭

Analysis of the drug therapy of gatifloxacin and levofloxacin in the treatment of acute bacterial conjunctivitis

用户Fm8QqQDltcks 5天前 10 已关闭

Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations

用户uXKlPLrO8Jz4 5天前 10 已完结

Evaluation of Torsadogenic Risk Drugs Using Human Ipscs Derived Cardiomyocytes Based Dual-Cardiotoxicity Evaluation Method

用户9SnxwkXmeW_E 6天前 10 已完结
首页 上页 10 11 12 13 14 15 16 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com